- Home
- NEOV vs LFCR Comparison
NEOV vs LFCR Comparison
Compare NEOV & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEOV | LFCR |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.3M | 143.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | NEOV | LFCR |
|---|---|---|
| Price | $1.87 | $5.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.5M | 175.7K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | $150.56 | N/A |
| Revenue Next Year | $5.31 | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.36 | $3.63 |
| 52 Week High | $7.13 | $8.98 |
Technical Indicators
Market Signals| Indicator | NEOV | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 64.90 |
| Support Level | $1.36 | $4.75 |
| Resistance Level | $3.22 | $5.92 |
| Average True Range (ATR) | 0.19 | 0.28 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 14.78 | 88.40 |
Price Performance
Historical ComparisonAbout NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.